Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (21)
Thomas C. McHale, David R. Boulware, John Kasibante, Kenneth Ssebambulidde, Caleb P. Skipper & Mahsa Abassi. (2023) Diagnosis and management of cryptococcal meningitis in HIV-infected adults. Clinical Microbiology Reviews.
Crossref
Crossref
Cecília Rocha da Silva, Livia Gurgel do Amaral Valente Sá, Thais Lima Ferreira, Amanda Cavalcante Leitão, Vitória Pessoa de Farias Cabral, Daniel Sampaio Rodrigues, Amanda Dias Barbosa, Lara Elloyse Almeida Moreira, Hugo Leonardo Pereira Filho, João Batista de Andrade Neto, Maria Erivanda França Rios, Bruno Coêlho Cavalcanti, Hemerson Iury Ferreira Magalhães, Manoel Odorico de Moraes & Hélio Vitoriano Nobre. (2023) Antifungal activity of selective serotonin reuptake inhibitors against Cryptococcus spp. and their possible mechanism of action. Journal of Medical Mycology 33:4, pages 101431.
Crossref
Crossref
Vinicius Alves, Glauber RS Araújo & Susana Frases. (2023) Off-label treatments as potential accelerators in the search for the ideal antifungal treatment of cryptococcosis. Future Microbiology 18:2, pages 127-135.
Crossref
Crossref
Matthew R. Breuer, Ananya Dasgupta, Joseph G. Vasselli, Xiaorong Lin, Brian D. Shaw & Matthew S. Sachs. (2022) The Antidepressant Sertraline Induces the Formation of Supersized Lipid Droplets in the Human Pathogen Cryptococcus neoformans. Journal of Fungi 8:6, pages 642.
Crossref
Crossref
Deborah Yamamura & Jianping Xu. (2021) Update on Pulmonary Cryptococcosis. Mycopathologia 186:5, pages 717-728.
Crossref
Crossref
Lucie Peyclit, Hanane Yousfi, Jean-Marc Rolain & Fadi Bittar. (2021) Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi. Pharmaceuticals 14:5, pages 488.
Crossref
Crossref
Luana Rossato, Marielle Camargo dos Santos, Roxana G. Vitale, Sybren de Hoog & Kelly Ishida. (2020) Alternative treatment of fungal infections: Synergy with non‐antifungal agents. Mycoses 64:3, pages 232-244.
Crossref
Crossref
David R Boulware, Elizabeth Nalintya, Radha Rajasingham, Paul Kirumira, Rose Naluyima, Fred Turya, Sylvia Namanda, Morris K Rutakingirwa, Caleb P Skipper, Yofesi Nikweri, Kathy Huppler Hullsiek, Ananta S Bangdiwala & David B Meya. (2020) Adjunctive sertraline for asymptomatic cryptococcal antigenemia: A randomized clinical trial. Medical Mycology 58:8, pages 1037-1043.
Crossref
Crossref
Gina Wall & Jose L. Lopez-Ribot. (2020) Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity. Antimicrobial Agents and Chemotherapy 64:9.
Crossref
Crossref
Ali A. Alhadab & Richard C. Brundage. (2020) Physiologically‐Based Pharmacokinetic Model of Sertraline in Human to Predict Clinical Relevance of Concentrations at Target Tissues. Clinical Pharmacology & Therapeutics 108:1, pages 136-144.
Crossref
Crossref
Cristina de Castro Spadari, Fernanda Wirth, Luciana Biagini Lopes & Kelly Ishida. (2020) New Approaches for Cryptococcosis Treatment. Microorganisms 8:4, pages 613.
Crossref
Crossref
Ali A. Alhadab, Joshua Rhein, Lillian Tugume, Abdu Musubire, Darlisha A. Williams, Mahsa Abassi, Melanie R. Nicol, David B. Meya, David R. Boulware & Richard C. Brundage. (2019) Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis. Journal of Pharmacokinetics and Pharmacodynamics 46:6, pages 565-576.
Crossref
Crossref
Paweł Krzyżek, Roman Franiczek, Barbara Krzyżanowska, Łukasz Łaczmański, Paweł Migdał & Grażyna Gościniak. (2019) In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains. Pathogens 8:4, pages 228.
Crossref
Crossref
Marissa B. Serafin, Angelita Bottega, Vitória S. Foletto, Taciéli F. da Rosa, Catrine S. Machado, Silvana S. Coelho, Sara de Lima Marion & Rosmari Hörner. (2019) Drug Repurposing Identifies New Promising Treatment Options for Invasive Fungal Diseases. Clinical Therapeutics 41:11, pages 2454-2459.
Crossref
Crossref
Joshua Rhein, Kathy Huppler Hullsiek, Lillian Tugume, Edwin Nuwagira, Edward Mpoza, Emily E Evans, Reuben Kiggundu, Katelyn A Pastick, Kenneth Ssebambulidde, Andrew Akampurira, Darlisha A Williams, Ananta S Bangdiwala, Mahsa Abassi, Abdu K Musubire, Melanie R Nicol, Conrad Muzoora, David B Meya, David R Boulware, Joshua Rhein, Kathy Huppler Hullsiek, Lillian Tugume, Edwin Nuwagira, Edward Mpoza, Emily E Evans, Reuben Kiggundu, Katelyn A Pastick, Kenneth Ssebambulidde, Andrew Akampurira, Darlisha A Williams, Ananta S Bangdiwala, Mahsa Abassi, Abdu K Musubire, Melanie R Nicol, Conrad Muzoora, David B Meya, David R Boulware, Jane Francis Ndyetukira, Cynthia Ahimbisibwe, Florence Kugonza, Carolyne Namuju, Alisat Sadiq, Alice Namudde, James Mwesigye, Kiiza K Tadeo, Paul Kirumira, Michael Okirwoth, Tonny Luggya, Julian Kaboggoza, Eva Laker, Leo Atwine, Davis Muganzi, Stewart Walukaga, Bilal Jawed, Matthew Merry, Anna Stadelman, Nicole Stephens, Andrew G Flynn, Ayako W Fujita, Richard Kwizera, Liliane Mukaremera, Sarah M Lofgren, Fiona V Cresswell, Bozena M Morawski, Nathan C Bahr & Kirsten Nielsen. (2019) Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial. The Lancet Infectious Diseases 19:8, pages 843-851.
Crossref
Crossref
Lin Cong, Yong Liao, Suteng Yang & Rongya Yang. (2016) In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates. PLOS ONE 11:12, pages e0167903.
Crossref
Crossref
Joshua Rhein, Bozena M Morawski, Kathy Huppler Hullsiek, Henry W Nabeta, Reuben Kiggundu, Lillian Tugume, Abdu Musubire, Andrew Akampurira, Kyle D Smith, Ali Alhadab, Darlisha A Williams, Mahsa Abassi, Nathan C Bahr, Sruti S Velamakanni, James Fisher, Kirsten Nielsen, David B Meya & David R Boulware. (2016) Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study. The Lancet Infectious Diseases 16:7, pages 809-818.
Crossref
Crossref
Rogelio de J. Treviño-Rangel, Hiram Villanueva-Lozano, Pedro Hernández-Rodríguez, Michel F. Martínez-Reséndez, Jaime García-Juárez, Humberto Rodríguez-Rocha & Gloria M. González. (2016)
Activity of sertraline against
Cryptococcus neoformans
:
in vitro
and
in vivo
assays
. Medical Mycology 54:3, pages 280-286.
Crossref
Crossref
Alexander Idnurm & Xiaorong Lin. (2015) Rising to the challenge of multiple Cryptococcus species and the diseases they cause. Fungal Genetics and Biology 78, pages 1-6.
Crossref
Crossref
Alexander Idnurm & Jianping Xu. 2012. Evolution of Virulence in Eukaryotic Microbes. Evolution of Virulence in Eukaryotic Microbes
208
230
.
Bing Zhai, Cheng Wu, Linqi Wang, Matthew S. Sachs & Xiaorong Lin. (2012) The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections. Antimicrobial Agents and Chemotherapy 56:7, pages 3758-3766.
Crossref
Crossref